# Glial Fibrillary Acidic Protein (GFAP) and Ubiquitin Carboxy-terminal Hydrolase L1 (UCH-L1) to Exclude Lesions Linked to Significant Traumatic Brain Injuries

> **NCT05885529** · — · RECRUITING · sponsor: **Centre Hospitalier Princesse Grace** · enrollment: 1500 (estimated)

## Conditions studied

- Traumatic Brain Injury

## Interventions

- **OTHER:** UCH-L1 GFAP

## Key facts

- **NCT ID:** NCT05885529
- **Lead sponsor:** Centre Hospitalier Princesse Grace
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-04-19
- **Primary completion:** 2025-12-15
- **Final completion:** 2026-03-30
- **Target enrollment:** 1500 (ESTIMATED)
- **Last updated:** 2025-02-19

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05885529

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05885529, "Glial Fibrillary Acidic Protein (GFAP) and Ubiquitin Carboxy-terminal Hydrolase L1 (UCH-L1) to Exclude Lesions Linked to Significant Traumatic Brain Injuries". Retrieved via AI Analytics 2026-07-11 from https://api.ai-analytics.org/clinical/NCT05885529. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*